Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, In Combination Therapy Across Range Of Treatment-Experienced Patients

... At this week's major HIV/AIDS research meeting, Pfizer presented pivotal data of its experimental medicine, maraviroc, which tackles HIV in an entirely new way. A 24 week analysis showed that approximately twice as many patients receiving maraviroc with an optimized background regimen achieved undetectable virus in the blood than if an optimized regimen was given alone. [click link for full article] ...